Elanco, Ginkgo Bioworks leverage microbiome technology


Global animal health company Elanco and horizontal platform for cell programming Ginkgo Bioworks have launched BiomEdit, a microbiome innovation company.

BiomEdit intends to discover, develop, and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial ...

Sign in  as a member, or Join our Community  for free to unlock the full article.